Articles with public access mandates - Yuchuan WangLearn more
Not available anywhere: 2
Biodistribution and dosimetry in human healthy volunteers of the PET radioligands [11C]CHDI-00485180-R and [11C]CHDI-00485626, designed for quantification …
A Delva, M Koole, K Serdons, G Bormans, L Liu, J Bard, V Khetarpal, ...
European Journal of Nuclear Medicine and Molecular Imaging 50 (1), 48-60, 2022
Mandates: Research Foundation (Flanders)
Molecular SPECT Imaging Instrumentation and Techniques
BMW Tsui, Y Wang, SP Mok
Molecular Imaging in Oncology, 93-108, 2008
Mandates: US National Institutes of Health
Available somewhere: 39
Selective inhibition of BET bromodomains
P Filippakopoulos, J Qi, S Picaud, Y Shen, WB Smith, O Fedorov, ...
Nature 468 (7327), 1067-1073, 2010
Mandates: US National Institutes of Health, Canadian Institutes of Health Research …
A murine lung cancer co-clinical trial identifies genetic modifiers of therapeutic response
Z Chen, K Cheng, Z Walton, Y Wang, H Ebi, T Shimamura, Y Liu, ...
Nature 483 (7391), 613-617, 2012
Mandates: US National Institutes of Health
Neuroinflammation and Brain Atrophy in Former NFL Players: An< i> in vivo</i> Multimodal Imaging Pilot Study
JM Coughlin, Y Wang, CA Munro, S Ma, C Yue, S Chen, R Airan, PK Kim, ...
Neurobiology of Disease, 2014
Mandates: US National Institutes of Health
Characterization of Torin2, an ATP-competitive inhibitor of mTOR, ATM, and ATR
Q Liu, C Xu, S Kirubakaran, X Zhang, W Hur, Y Liu, NP Kwiatkowski, ...
Cancer research 73 (8), 2574-2586, 2013
Mandates: US National Institutes of Health, Howard Hughes Medical Institute
Inhibition of ALK, PI3K/MEK, and HSP90 in murine lung adenocarcinoma induced by EML4-ALK fusion oncogene
Z Chen, T Sasaki, X Tan, J Carretero, T Shimamura, D Li, C Xu, Y Wang, ...
Cancer research 70 (23), 9827-9836, 2010
Mandates: US National Institutes of Health
Translational evaluation of translocator protein as a marker of neuroinflammation in schizophrenia
T Notter, JM Coughlin, T Gschwind, U Weber-Stadlbauer, Y Wang, ...
Molecular psychiatry 23 (2), 323-334, 2018
Mandates: Swiss National Science Foundation, UK Medical Research Council
PET imaging of microglia by targeting macrophage colony-stimulating factor 1 receptor (CSF1R)
AG Horti, R Naik, CA Foss, I Minn, V Misheneva, Y Du, Y Wang, ...
Proceedings of the National Academy of Sciences 116 (5), 1686-1691, 2019
Mandates: US National Institutes of Health
Imaging of glial cell activation and white matter integrity in brains of active and recently retired National Football League players
JM Coughlin, Y Wang, I Minn, N Bienko, EB Ambinder, X Xu, ME Peters, ...
JAMA neurology 74 (1), 67-74, 2017
Mandates: US National Institutes of Health
In vivo markers of inflammatory response in recent-onset schizophrenia: a combined study using [11 C] DPA-713 PET and analysis of CSF and plasma
JM Coughlin, Y Wang, EB Ambinder, RE Ward, I Minn, M Vranesic, ...
Translational psychiatry 6 (4), e777-e777, 2016
Mandates: US National Institutes of Health
Positron emission tomography studies of the glial cell marker translocator protein in patients with psychosis: a meta-analysis using individual participant data
P Plavén-Sigray, GJ Matheson, K Collste, AH Ashok, JM Coughlin, ...
Biological psychiatry 84 (6), 433-442, 2018
Mandates: US Department of Defense, US National Institutes of Health, American Heart …
Cannabinoid CB2 receptors in a mouse model of Aβ amyloidosis: immunohistochemical analysis and suitability as a PET biomarker of neuroinflammation
AV Savonenko, T Melnikova, Y Wang, H Ravert, Y Gao, J Koppel, D Lee, ...
PLoS One 10 (6), e0129618, 2015
Mandates: US National Institutes of Health
Regional brain distribution of translocator protein using [11C] DPA-713 PET in individuals infected with HIV
JM Coughlin, Y Wang, S Ma, C Yue, PK Kim, AV Adams, HV Roosa, ...
Journal of neurovirology 20 (3), 219-232, 2014
Mandates: US National Institutes of Health
18F-ASEM, a radiolabeled antagonist for imaging the α7-nicotinic acetylcholine receptor with PET
AG Horti, Y Gao, H Kuwabara, Y Wang, S Abazyan, RP Yasuda, T Tran, ...
Journal of Nuclear Medicine 55 (4), 672-677, 2014
Mandates: US National Institutes of Health
Co-clinical trials demonstrate superiority of crizotinib to chemotherapy in ALK-rearranged non–small cell lung cancer and predict strategies to overcome resistance
Z Chen, E Akbay, O Mikse, T Tupper, K Cheng, Y Wang, X Tan, A Altabef, ...
Clinical Cancer Research 20 (5), 1204-1211, 2014
Mandates: US National Institutes of Health
Development of a high-affinity PET radioligand for imaging cannabinoid subtype 2 receptor
RP Moldovan, R Teodoro, Y Gao, W Deuther-Conrad, M Kranz, Y Wang, ...
Journal of Medicinal Chemistry 59 (17), 7840-7855, 2016
Mandates: US National Institutes of Health, German Research Foundation
Quantification of the multiplexing effects in multi-pinhole small animal SPECT: a simulation study
GSP Mok, Y Wang, BMW Tsui
IEEE transactions on nuclear science 56 (5), 2636-2643, 2009
Mandates: US National Institutes of Health
64Cu] XYIMSR-06: A dual-motif CAIX ligand for PET imaging of clear cell renal cell carcinoma.
I Minn, SM Koo, HS Lee, M Brummet, SP Rowe, MA Gorin, P Sysa-Shah, ...
Oncotarget, 2016
Mandates: US National Institutes of Health
A PSMA-targeted theranostic agent for photodynamic therapy
Y Chen, S Chatterjee, A Lisok, I Minn, M Pullambhatla, B Wharram, ...
Journal of Photochemistry and Photobiology B: Biology 167, 111-116, 2017
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program